# ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization

> **NCT03370536** · NA · TERMINATED · sponsor: **Vivek Reddy** · enrollment: 1 (actual)

## Conditions studied

- Atrial Fibrillation
- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** CardioInsight ECGI Mapping System
- **PROCEDURE:** AF ablation
- **DRUG:** Ibutilide

## Key facts

- **NCT ID:** NCT03370536
- **Lead sponsor:** Vivek Reddy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-07-18
- **Final completion:** 2018-07-18
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** 1 patient enrolled (consented) but screen failed. Study stopped as unable to enroll.
- **Last updated:** 2020-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370536, "ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03370536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*